Literature DB >> 29456377

Molecular Simulation Studies of 3,3'-Diindolylmethane as a Potent MicroRNA-21 Antagonist.

Md Junaid1,2, Raju Dash3,2, Nazrul Islam1, Jui Chowdhury1, Md Jahangir Alam1, Saikat Dev Nath4, Mohammad Abu Sayem Shakil1, Ashifa Azam1, Syed Mustyen Quader1, S M Zahid Hosen2.   

Abstract

OBJECTIVE: In recent decades, the overexpression of microRNA-21 (miR-21) is found to be progressively linked with many diseases such as different types of cancers, cardiovascular diseases, and inflammation. Thereby, it has become an attractive target for pharmacological and genetic modulation in various diseases, and also for overcoming the resistance to chemotherapy in several cancers. Here, in this study, the role of molecular therapeutics of 3,3'-diindolylmethane (DIM) has been investigated for its ability to bind with the precursor miRNA as a target of miR-21 (hsa-mir-21), which may alter the catalyzation process of dicer, a RNase III enzyme, involved in miRNA transcription.
METHODS: In this context, the present study describes the potential binding and the structure alteration properties of DIM to precursor miR-21 (pre-miR-21) through Molecular Docking and Molecular Dynamics simulation techniques.
RESULTS: As a corollary, DIM formed both non-bonded and covalent interactions with the bases of pre-miR, while covalent interaction with guanine in the 6th position was found to be consensus in molecular dynamics simulation. Furthermore, the stability of both DIM and pre-miR-21 was found to be inversely correlated to each other in binding condition.
CONCLUSION: This result indicates that DIM can be used in target-based therapy and also as a lead for further development of potent small molecule miRNA antagonist.

Entities:  

Keywords:  3,3′-Diindolylmethane; cancer; miR-21; molecular docking; molecular dynamics simulation; pre-miR-21

Year:  2017        PMID: 29456377      PMCID: PMC5810076          DOI: 10.4103/jpbs.JPBS_266_16

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


INTRODUCTION

MicroRNAs (miRNAs) are the new findings of genes family consisting of 19–25 nucleotides in length which are nonprotein coding in nature but act as a major player in the regulation of gene expression by post-transcriptional interactions with mRNA.[1] Over 1000 human miRNAs have been discovered so far,[2] and they are predicted to target up to 92% of all human genes.[3] In the human genome, miR-21 (hsa-miR-21) was one of the first detected miRNAs, which was known to be upregulated in all types of human cancer including glioblastoma,[4] breast,[5] lung,[6] esophageal,[7] gastrointestinal,[8] hepatocellular,[9] cholangiocarcinoma,[10] pancreatic,[11] prostate,[12] bladder,[13] ovarian,[14] NK-cell lymphoma,[15] laryngeal carcinoma,[16] and tongue squamous cell carcinoma.[17] Until now, various experiments have been conducted to determine the physiological and pathophysiological functions of miR-21, where its major functions involved embryonic development and cell proliferation, differentiation, and death.[18192021] Recently, extensive studies are indicating that excessive expression of miR-21 is involved in all known cancer-related processes including tumor genesis, progression, and metastasis.[21222324] Furthermore, improving chemosensitivity to anticancer agents and inducing cell cycle arrest by inhibition of miR-21 concluded that miR-21 may function as an oncogene in various human cancers.[79112125] In traditional theory, oligonucleotide-based gene therapy approaches such as synthetic miRNA, antagomir, and miRNA sponge/decoy are usually used for the miRNA functional studies and for therapeutic intervention.[2627] Nevertheless, due to their limitations such as chemical instability, cellular delivery, and inappropriate biodistribution,[28] nowadays, other techniques based on small molecular chemical biology have been followed.[2930313233] Particularly, small molecules may directly bind to the miRNA and alter its functions. In general, most of the miRNA are formed in cell by the dicer-catalyzed processing of their corresponding inactive precursor miRNA (pre-miRNA) and this step has been proposed as an appropriate target for inhibitor design.[3435363738] Furthermore, high affinity synthetic small molecule ligands have been recently described to bind with pre-miRNA.[383940] In this regard, we aim to analyze the binding properties of 3,3′-diindolylmethane (DIM) with pre-miR-21, as a potential inhibitor of miR-21. DIM is a natural compound that is abundant in cruciferous vegetables such as broccoli, cauliflower, and cabbage, and it is a major acid condensation product of indole-3-carbinol.[41] DIM has been demonstrated to reduce the expression of certain miRNAs. It inhibits cancer cell growth by controlling cell proliferation, transcription, and apoptosis through regulation of gene expression. Moreover, it is evident that it reverses the expression level of oncogenic miRNAs by inhibiting the expression of miR-21.[42] Results showed that the inhibition of endogenous miR-21 is specific, efficient in the treatment of cancer.[42] Coupled with that, the present study is designed with some computer-aided drug discovery methods such as molecular docking and molecular dynamics simulation to investigate the bindings and the changes in the dynamics behavior of functional region of pre-miRNAs. As we know that conformational changes in the protein or macromolecules structure affect its biological function, and also it is evident that the conformational flexibility of a macromolecule influences the interactions with ligand or its biological partners at different level.[4243]

MATERIALS AND METHODS

Data and databases

The data from databases used in this study include protein data bank (PDB)[44] and PubChem.[45] PubChem is a public repository of small molecules and their biological properties. Currently, it contains more than 25 million unique chemical structures and 90 million bioactivity outcomes associated with several thousand macromolecular targets.[46]

Ligand selection and preparation

For docking studies, compound was retrieved from Pubchem databases, i.e., DIM (CID 3071). The 3D structure for this compound was built by using Ligprep2.5 in Schrödinger Suite 2013 with OPLS_2005 force field. Their ionization states were generated at pH7.0 ± 2.0 using Epik2.2 in Schrödinger Suite. Up to 32 possible stereoisomers per ligand were retained.

MicroRNA structure preparation

The NMR solution structure of pre-miR-21 having lowest energy was obtained from (pdb id: 2MNC).[44] The solution structure of pre-miR-21 (CCGUUGAAUCUCACGG) was prepared and refined by using the Protein Preparation Wizard of Schrödinger-Maestro v9.4. Charges and bond orders were assigned, hydrogens were added to the heavy atoms, and all waters were deleted. It was optimized at neutral pH. Using force field OPLS_2005, minimization was carried out setting maximum heavy atom root mean square deviation (RMSD) to 0.30 Å.

Docking simulation study

Before docking, the structures were prepared by using dock preparation wizard integrated in UCSF Chimera,[47] by adding hydrogen and Gasteiger charges.[48] Input ligand file format was MOL2, so these were further converted into pdbqt format by Python Molecular Viewer with AutoDock tools, required by AutoDock Vina.[49] The size of grid box in AutoDock Vina was kept at 30.72, 25.00, and 25.00, respectively, for X, Y, and Z. The energy range was kept at 4 which was default setting. AutoDock Vina was implemented through shell script provided by AutoDock Vina developers. The binding affinity of ligand was observed by Kcal/Mol as a unit for a negative score.[50]

Molecular dynamics simulation

Molecular dynamics simulation was performed using the NAMD[51] engine integrated in MOE software. In this study, the AMBER12:EHT (Extended Huckel Theory Group II ion and Group VIII parameters OPLS-AA) force field was utilized, as it is widely applied to describe macromolecular system. The system was solvated and neutralized by adding Cl− and/or Na+ ions and water molecules, where the total solvent molecules was 1827; 1.023 g/cm3. The periodic boundary condition was employed to perform the simulation, where the box size was 43.3 Å × 38.0 Å × 38.1 Å. Following steepest descent energy minimization, equilibration of 100 steps done in NPT ensemble with Periodic Boundary Conditions, Particle Mesh Ewald for full-system periodic electrostatics, and constant temperature dynamics through Langevin Dynamics, constant pressure dynamics through Nose-Hoover Langevin piston, and SHAKE was used to maintain all bonds involving hydrogen atoms at their equilibrium values. Finally, the full system was subjected to molecular dynamics (MD) production run at 300 K temperature for 10 ns in NVT ensemble.

RESULTS AND DISCUSSION

Molecular docking is one of the most computational techniques, which not only predicts the binding affinity of a ligand to a receptor but also demonstrates the binding mode in the particular active site. We therefore performed docking analysis to understand the molecular interactions of DIM in binding with miR-21. In essence, DIM formed three conventional hydrogen bonds with U11, U12 bases, where a hydrogen bond was formed with the oxygen atoms of 11th uridine and rest of two were formed with another oxygen atom of 12th uridine. Moreover, a π-π interaction was observed between the indole ring and the purine ring of 20th adenine. A detailed description of the DIM binding with miR-21 is demonstrated in Table 1 and also rendered in Figure 1. According to the docking analysis, the binding affinity of DIM was found to have −7.3 kcal/mol, which may indicate a strong binding with pre-miR-21. On this side, analysis of complex stability was carried out using long MD simulations to support the docking prediction, which is described in further sections.
Table 1

Molecular interactions analysis of 3,3′-diindolylmethane pre-microRNA-21 complex, after docking and molecular dynamics simulation

Figure 1

Interactions and binding pose of 3,3′-diindolylmethane with precursor microRNA-21 complex were generated from AutoDock Vina. Here, green dots represent hydrogen bonding, while pink represent pi-pi T-shaped

Molecular interactions analysis of 3,3′-diindolylmethane pre-microRNA-21 complex, after docking and molecular dynamics simulation Interactions and binding pose of 3,3′-diindolylmethane with precursor microRNA-21 complex were generated from AutoDock Vina. Here, green dots represent hydrogen bonding, while pink represent pi-pi T-shaped To impart stability, the pre-miR-21-DIM complex was subjected to a MD simulation for 10 ns. The energy profile of the system such as the potential energy and kinetic energy and the other factors such as temperature and pressure are rendered in Figure 2. As described in Figure 2, it can be concluded that the system had been reached at equilibration and remained stable in 10 ns simulation. Moreover, the volume of the system remained constant at the time of simulation, which is 62610.11 Å3. To describe the stability and flexibility of the ligand binding, we calculated the RMSD profile of both miR-21 and DIM along with the time steps. As can be seen in Figure 3, the RMSD of the backbone of miR-21 increased from ~1 Å at 0 ns to 3 Å at 1 ns and remained stable at 2–3 Å for 3.75 ns. After that, it then increased to 4 Å and remained stable for 8 ns. However, following 8 ns, the RMSD is tending to decrease, which means that the miRNA is somewhat stable in the simulation, afterward. In contrast, the RMSD of DIM remained stable at ~1 Å, from 0 ns to 8.5 ns. Nevertheless, it increased to ~2 Å and seems to lose its stability afterward. Interestingly, it can be assumed from the RMSD plot that in bounding with DIM, the pre-miR-21 was less stable for 8 ns, while DIM was found to be more stable at that time. In this manner, after 8 ns, the stability of DIM was decreased, while the stability of pre-miR-21 increased. To justify this hypothesis, we examined the molecular interactions of the complex in different snapshot of MD simulation. According to Table 1 and Figure 4, it is observed that the DIM formed conventional hydrogen bonds with U4 and G6 bases in 1 ns and 5 ns snapshot and also had covalent interactions by forming carbon–hydrogen bonds with U4, A13, and C4 bases. Similarly, in 8 ns and 9 ns simulation snapshot, G6 base was involved in both noncovalent and covalent interactions with DIM; however, only one covalent interaction remained in 10 ns simulation. As a corollary, the number of bonding interaction was gradually decreasing by the increasing of time step in the simulation, which means that increasing of DIM flexibility after 8 ns is due to the breaking down of its bonding interactions with pre-miR-21.
Figure 2

Stability of the simulation system. Stability was evaluated in terms of the (a) potential energies, (b) kinetic energies, (c) pressure, (d) temperature of the simulation as a function of simulation time

Figure 3

Backbone root mean square deviations are shown as a function of time for precursor microRNA-21 and 3,3′-diindolylmethane at 300 K. Here, precursor microRNA-21 is shown in black and 3,3′-diindolylmethane in red

Figure 4

Two-dimensional representation of molecular interactions between the precursor microRNA-21 and 3,3′-diindolylmethane, complexes were sampled from molecular dynamics simulation. The interactions were rendered by Ligplot

Stability of the simulation system. Stability was evaluated in terms of the (a) potential energies, (b) kinetic energies, (c) pressure, (d) temperature of the simulation as a function of simulation time Backbone root mean square deviations are shown as a function of time for precursor microRNA-21 and 3,3′-diindolylmethane at 300 K. Here, precursor microRNA-21 is shown in black and 3,3′-diindolylmethane in red Two-dimensional representation of molecular interactions between the precursor microRNA-21 and 3,3′-diindolylmethane, complexes were sampled from molecular dynamics simulation. The interactions were rendered by Ligplot Our findings from the molecular docking and molecular dynamics simulation studies suggested that DIM has the potential chemical affinity and ability to alter the stability of pre-miRNA of miR-21. These results postulate DIM as an important ligand of potential importance for the development of potent small molecular miRNA antagonist and the remedial approaches in various cancers.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  51 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Rotamer libraries in the 21st century.

Authors:  Roland L Dunbrack
Journal:  Curr Opin Struct Biol       Date:  2002-08       Impact factor: 6.809

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  Macrocyclic helix-threading peptides for targeting RNA.

Authors:  Malathy Krishnamurthy; Kristina Simon; Anita M Orendt; Peter A Beal
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 5.  Bio-inspired algorithms applied to molecular docking simulations.

Authors:  G Heberlé; W F de Azevedo
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Distinct microRNA alterations characterize high- and low-grade bladder cancer.

Authors:  James W F Catto; Saiful Miah; Helen C Owen; Helen Bryant; Katie Myers; Ewa Dudziec; Stéphane Larré; Marta Milo; Ishtiaq Rehman; Derek J Rosario; Erica Di Martino; Margaret A Knowles; Mark Meuth; Adrian L Harris; Freddie C Hamdy
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

7.  Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.

Authors:  Yasuo Yamanaka; Hiroyuki Tagawa; Naoto Takahashi; Atsushi Watanabe; Yong-Mei Guo; Keiko Iwamoto; Junsuke Yamashita; Hirobumi Saitoh; Yoshihiro Kameoka; Norio Shimizu; Ryo Ichinohasama; Ken-ichi Sawada
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

8.  MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.

Authors:  Jinsong Li; Hongzhang Huang; Lijuan Sun; Mei Yang; Chaobin Pan; Weiliang Chen; Donghui Wu; Zhaoyu Lin; Chunxian Zeng; Yandan Yao; Peter Zhang; Erwei Song
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  PubChem BioAssay: 2014 update.

Authors:  Yanli Wang; Tugba Suzek; Jian Zhang; Jiyao Wang; Siqian He; Tiejun Cheng; Benjamin A Shoemaker; Asta Gindulyte; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2013-11-05       Impact factor: 16.971

View more
  4 in total

1.  Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function.

Authors:  Raju Dash; Yeasmin Akter Munni; Sarmistha Mitra; Ho Jin Choi; Sultana Israt Jahan; Apusi Chowdhury; Tae Jung Jang; Il Soo Moon
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

2.  A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway.

Authors:  Hongyan Du; Xi Zhang; Yongchang Zeng; Xiaoming Huang; Hao Chen; Suihai Wang; Jing Wu; Qiang Li; Wei Zhu; Hongwei Li; Tiancai Liu; Qinghong Yu; Yingsong Wu; Ligang Jie
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

Review 3.  3,3'-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs.

Authors:  Bernhard Biersack
Journal:  Cancer Drug Resist       Date:  2020-10-12

4.  Structural Consequence of Non-Synonymous Single-Nucleotide Variants in the N-Terminal Domain of LIS1.

Authors:  Ho Jin Choi; Sarmistha Mitra; Yeasmin Akter Munni; Raju Dash; Sarmin Ummey Habiba; Md Sohel; Sultana Israt Jahan; Tae Jung Jang; Il Soo Moon
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.